SEP 20, 2016 07:00 AM PDT

Advanced Analysis of Complex Cell Models with the New Operetta CLS HCA System

  • Senior Field Applications Scientist, PerkinElmer
      Joe joined PerkinElmer in July 2016 and is instrumental in strategic customer support through teaching, training, and collaborations. He brings over 20 years of experience in high content screening technology from academia (Duke University and The Ohio State University), pharmaceutical industry (Abbott Laboratories and Sphinx Laboratories, Division of Eli Lilly & Company), and biotechnology (The Hamner Institute for Health Sciences and ScitoVation). Joe has extensive experience in cell based technologies from flow cytometry, confocal microscopy and computer-assisted automated microscopy studying cancer, immunology, neurodegeneration, and toxicology. Joe has published several research articles and book chapters in High Content Imaging field, and is an author and co-editor to the NIH/NCATS Assay Guidance Manual. Joe was a co-founder and first President of Society for Biomolecular Imaging and Informatics (SBI2).
    • Portfolio Director, PerkinElmer
        As portfolio director for high content instruments, Dr. Tesdorpf is leading the global product management and application development for high content screening and live cell imaging at PerkinElmer. He holds a doctorate in biochemistry from Hannover University and did research on nuclear hormone receptors at the Max-Planck-Institute. Dr. Tesdorpf held several imaging related sales and marketing roles at Molecular Dynamics, Amersham Biosciences and GE Healthcare looking after proteomics, microarrays, pre-clinical imaging and high content analysis software. Prior to joining PerkinElmer in 2010 Dr. Tesdorpf headed the marketing group at 5 PRIME GmbH a supplier of nucleic acid purification and amplification products.

      DATE: September 20th, 2016
      TIME:  7:00AM PST, 10:00AM ET

      There is a growing trend towards developing in vitro cell models that recapitulate the in vivo environment in basic research, developmental biology, drug discovery, and toxicology. To achieve this, scientists are using more complex cellular models such as ex vivo tissue, primary cells, stem cells, or a combination of co-culture cells to form 3D structures or scaffolds to generate detailed phenotypic fingerprints for deeper biological insights in both live cell and fixed endpoint assays.
      In this webinar, we will show how the advanced features of the new Operetta CLSTM high-content analysis system from PerkinElmer can help you to achieve the throughput to assess varied conditions, the resolution to capture high-quality image data and insights from the data.   

      Key Learning Objectives
      What you will learn:
      • How you can achieve increased sensitivity, speed and quality when imaging 3D microtissues such as liver cells and stem cell colonies
      • Advantages of the confocality, high NA water immersion objectives and powerful  8-color LED excitation provided by the Operetta CLS system
      • How the intelligent scanning software feature - PreciScan - enables more efficient screening of 3D microtissues
      • Tools to develop assays for complex biological designs including 3D image capture
      Who should attend
      Researchers who are interested in:
      • High-content imaging and analysis
      • Complex cell models for generating more physiologically relevant data
      • Developmental biology, oncology, neurobiology, toxicology, stem cell research
      • Systems biology and phenotypic fingerprinting
      • Advanced cell-based assays

      Show Resources
      Loading Comments...